EPAS1 and polycythemia: These findings were further corroborated by other recent studies that confirmed somatic HIF2A gain-of-function mutations as causative for the development of polycythemia and multiple paragangliomas/pheochromocytomas and somatostatinomas in patients, corresponding to a novel syndrome [135–142].